Demosthenes Bouros (Athens, Greece), Paolo Spagnolo (Liestal, Switzerland), Dominique Valeyre (Paris, France), Paola Rottoli (Siena, Italy)
Cardiovascular magnetic resonance-guided diagnosis of cardiac sarcoidal affection
Carmen Pizarro (Bonn, Germany), Carmen Pizarro, Andreas Goebel, Stefan Pabst, Christian Grohé, Daniel Thomas, Dirk Skowasch
|   |
Benefits of physical training in patients with sarcoidosis
Bert Strookappe (Huissen, Netherlands), Bert Strookappe, Marjon Elfferich, Jeff Swigris, Ton Knevel, Marjolein Drent
| |
A comparison of two scoring methods for the King’s sarcoidosis questionnaire
Aish Sinha (Wolverhampton, United Kingdom), Aish Sinha, Sabrina Bajwah, Harry Gosker, Richard Siegert, Daniel Creamer, Genevieve Larkin, Toby Maher, Elisabetta Renzoni, Athol Wells, Irene Higginson, Surinder Birring, Amit Patel
| |
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Anna Kempisty (Warsaw, Poland), Anna Kempisty, Beata Bialas-Chromiec, Jan Kus
| |
A comparison of two scoring methods for the King’s brief interstitial lung disease questionnaire
Aish Sinha (Wolverhampton, United Kingdom), Aish Sinha, Sabrina Bajwah, Harry Gosker, Richard Siegert, Daniel Creamer, Genevieve Larkin, Toby Maher, Elisabetta Renzoni, Athol Wells, Irene Higginson, Surinder Birring, Amit Patel
| |
Fatigue in sarcoidosis; effect on quality of life and health status
Chris Atkins (Norwich, United Kingdom), Chris Atkins, Daniel Gilbert, Claire Brockwell, Sue Robinson, Andrew Wilson
| |
Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis
Zehra Asuk Yasar (Bolu, Turkey), Zehra Yasar, Erdogan Cetinkaya, Elif Tanriverdio, Aysel Kargi, Sule Gul, Fahrettin Talay, Akif Ozgül
| |
Optimal use of gas transfer values in detecting pulmonary vascular involvement in sarcoidosis
Vasileios Kouranos (Athens, Greece), Vasileios Kouranos, Simon Ward, Maria Kokosi, Joe Jacob, Diego Castillo, Felix Chua, Toby Maher, Andrew Nicholson, David Hansell, Elisabetta Renzoni, Athol Wells
| |
Steroid treatment effect in pulmonary sarcoidosis (STEPS study)
Caroline Broos (Rotterdam, Netherlands), Caroline Broos, Marlies Wijsenbeek, Leon Van den Toorn, Hans In ’t Veen, Roxane Heller, Marco Grootenboers, Monique Wapenaar, Henk Hoogsteden, Mirjam Kool, Bernt Van den Blink
| |
Comorbid illnesses in South African patients with sarcoidosis
Rajen Morar (Johannesburg, South Africa), Rajen Morar, Charles Feldman
| |
Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Vasileios Kouranos (Athens, Greece), Vasileios Kouranos, Aggeliki Rapti, Anastasios Kallianos, Ourania Anagnostopoulou, Ioannis Arapis, George Kaltsakas, Charalampos Kostopoulos, George Tzelepis, Nikolaos Koulouris, Petros Sfikakis, Athol Wells, Elias Gialafos
| |
Sarcoidosis in Johannesburg, South Africa: A retrospective study
Rajen Morar (Johannesburg, South Africa), Rajen Morar, Charles Feldman
| |
Evaluation of ventricular arrhythmogenesis in patients with sarcoidosis
Gülistan Karadeniz (Izmir, Turkey), Fatma Ucsular, Gulistan Karadeniz, Cem Karadeniz, Enver Yalniz, Melike Demir
| |
Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
Alexander Vizel (Kazan, Russian Federation), Irina Vizel, Alexander Vizel
| |
Subcutaneous sarcoidosis: A clinical analysis of nine patients
Masaru Ando (Oita, Japan), Masaru Ando, Mari Yamasue, Masataka Kan, Kenji Umiki, Shin-ichi Nureki, Yutaka Hatano, Eishi Miyazaki, Jun-ichi Kadota
| |
Role of infliximab in managing resistant ventricular arrhythmias in sarcoidosis
Shruthi Konda (London, United Kingdom), Shruthi Konda, Felix Chua, Magdi Saba, Ranjit Pagonda, Raminder Aul
| |
Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis
Regina Aleksoniene (Vilnius, Lithuania), Regina Aleksoniene, Ingrida Zeleckiene, Mindaugas Mataciunas, Roma Puronaite, Edvardas Danila
| |
Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Serge Lebecque (Lyon, France), Serge Lebecque, Toufic Renno, Azzak Bentaher, Marine Ponchon, Alain Calender, Jean-François Bernaudin, Dominique Valeyre, Marc Iglarz, Herve Farine, Daniel Strasser, Yves Pacheco
| |
Polymorphisms of activating FCGR2A and FCGR2C genes in the etiopathogenesis of sarcoidosis
Anna Dubaniewicz (Gdansk, Poland), Marlena Typiak, Krzysztof Rebala, Jan Marek Slominski, Zbigniew Jankowski, Anna Dubaniewicz
| |
Inorganic exposome in pediatric sarcoidosis: The PEDIASARC study
Nadia Nathan (Paris, France), Nadia Nathan, Catherine Cavallin, Odile Macchi, Rola Abou Taam, Dominique Valeyre, Veronique Houdouin, Harriet Corvol, Caroline Perisson, Abdellatif Tazi, Xavier Amiot, Ralph Epaud, Anne Houzel, Nassima Hamami, Antoine Deschildre, Jacques De Blic, Annick Clement, Michel Vincent, Paul-André Rosental
| |